441 related articles for article (PubMed ID: 18164829)
21. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
Meyers CA; Smith JA; Bezjak A; Mehta MP; Liebmann J; Illidge T; Kunkler I; Caudrelier JM; Eisenberg PD; Meerwaldt J; Siemers R; Carrie C; Gaspar LE; Curran W; Phan SC; Miller RA; Renschler MF
J Clin Oncol; 2004 Jan; 22(1):157-65. PubMed ID: 14701778
[TBL] [Abstract][Full Text] [Related]
22. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
Stea B; Suh JH; Boyd AP; Cagnoni PJ; Shaw E;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1023-30. PubMed ID: 16446056
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).
Manon R; O'Neill A; Knisely J; Werner-Wasik M; Lazarus HM; Wagner H; Gilbert M; Mehta M;
J Clin Oncol; 2005 Dec; 23(34):8870-6. PubMed ID: 16314647
[TBL] [Abstract][Full Text] [Related]
24. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.
Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):751-60. PubMed ID: 17560735
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
[TBL] [Abstract][Full Text] [Related]
26. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).
Roos DE; Wirth A; Burmeister BH; Spry NA; Drummond KJ; Beresford JA; McClure BE
Radiother Oncol; 2006 Sep; 80(3):318-22. PubMed ID: 16956684
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.
Regine WF; Scott C; Murray K; Curran W
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):711-7. PubMed ID: 11597813
[TBL] [Abstract][Full Text] [Related]
28. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
29. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
30. Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study.
Shibamoto Y; Baba F; Oda K; Hayashi S; Kokubo M; Ishihara S; Itoh Y; Ogino H; Koizumi M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1168-73. PubMed ID: 18495375
[TBL] [Abstract][Full Text] [Related]
31. Memory function before and after whole brain radiotherapy in patients with and without brain metastases.
Welzel G; Fleckenstein K; Schaefer J; Hermann B; Kraus-Tiefenbacher U; Mai SK; Wenz F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1311-8. PubMed ID: 18448270
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.
Aoyama H; Tago M; Kato N; Toyoda T; Kenjyo M; Hirota S; Shioura H; Inomata T; Kunieda E; Hayakawa K; Nakagawa K; Kobashi G; Shirato H
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1388-95. PubMed ID: 17674975
[TBL] [Abstract][Full Text] [Related]
33. Self-reported cognitive outcomes in patients with brain metastases before and after radiation therapy.
Cole AM; Scherwath A; Ernst G; Lanfermann H; Bremer M; Steinmann D
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):705-12. PubMed ID: 24064320
[TBL] [Abstract][Full Text] [Related]
34. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of pretreatment executive cognitive impairment and depression in patients referred for radiotherapy.
Fuller CD; Schillerstrom JE; Jones WE; Boersma M; Royall DR; Fuss M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):529-33. PubMed ID: 18411001
[TBL] [Abstract][Full Text] [Related]
36. Treatment of brain metastases: review of phase III randomized controlled trials.
Scoccianti S; Ricardi U
Radiother Oncol; 2012 Feb; 102(2):168-79. PubMed ID: 21996522
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.
Rades D; Kieckebusch S; Haatanen T; Lohynska R; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1319-24. PubMed ID: 18374222
[TBL] [Abstract][Full Text] [Related]
38. Cognitive functioning in patients with cerebral aneurysms measured with the mini mental state examination and the telephone interview for cognitive status.
King JT; DiLuna ML; Cicchetti DV; Tsevat J; Roberts MS
Neurosurgery; 2006 Oct; 59(4):803-10; discussion 810-1. PubMed ID: 17038944
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
40. Current management of brain metastases, with a focus on systemic options.
Langer CJ; Mehta MP
J Clin Oncol; 2005 Sep; 23(25):6207-19. PubMed ID: 16135488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
